Stonehearth Capital Management, LLC Bristol Myers Squibb CO Transaction History

Stonehearth Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 02, 2024	BUY	$47.98 - $54.4 $38,240 - $43,356	797 Added 9.95%	8,808 $477,000
Q4 2023 Jan 08, 2024	BUY	$48.48 - $57.85 $121,587 - $145,087	2,508 Added 45.58%	8,011 $411,000
Q3 2023 Oct 11, 2023	BUY	$57.89 - $64.73 $7,236 - $8,091	125 Added 2.32%	5,503 $319,000
Q2 2023 Jul 06, 2023	BUY	$63.71 - $70.74 $18,985 - $21,080	298 Added 5.87%	5,378 $343,000
Q1 2023 Apr 04, 2023	BUY	$65.71 - $74.53 $2,431 - $2,757	37 Added 0.73%	5,080 $352,000
Q4 2022 Jan 03, 2023	BUY	$68.48 - $81.09 $149,012 - $176,451	2,176 Added 75.9%	5,043 $0
Q3 2022 Oct 05, 2022	BUY	$0.13 - $76.84 $12 - $7,453	97 Added 3.5%	2,867 $204,000
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $170,299 - $204,204	2,770 New	2,770 $202,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Stonehearth Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonehearth Capital Management, LLC with notifications on news.